Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by University of Erlangen-Nürnberg Medical School.
Recruitment status was  Recruiting
Information provided by:
University of Erlangen-Nürnberg Medical School Identifier:
First received: January 14, 2009
Last updated: January 11, 2010
Last verified: January 2009
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2010
  Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)